Table 3.

Event Rate of Different Outcomes in NOAC and Warfarin Users

Outcome	NOACs (n=333)	Warfarin (n=205)	Adjusted HR
Ischemic stroke			0.92 (0.50–1.70)
No. of events	12	9
Person‐y	275.13	196.82
Event rate (95% CI)	53.42 (24.66–76.46)	45.73 (23.79–87.88)
Thromboembolism			0.81 (0.46–1.44)
No. of events	13	11
Person‐y	275.10	196.19
Event rate (95% CI)	47.22 (27.42–81.32)	56.07 (31.05–101.24)
Intracerebral hemorrhage			0.53 (0.22–1.30)
No. of events	5	6
Person‐y	284.42	196.53
Event rate (95% CI)	17.58 (7.32–42.24)	30.53 (13.72–67.96)
Major bleeding event			0.36 (0.22–0.60)
No. of events	13	18
Person‐y	281.96	187.84
Event rate (95% CI)	46.11 (26.77–79.40)	95.83 (60.38–152.10)
All‐cause mortality			0.60 (0.43–0.84)
No. of events	34	39
Person‐y	285.20	198.28
Event rate (95% CI)	119.22 (85.18–166.84)	196.69 (143.77–269.21)

HR indicates hazard ratio; and NOACs, non‐vitamin K antagonist oral anticoagulants.